Monte Rosa Therapeutics
GLUE
#7474
Rank
NZ$0.52 B
Marketcap
$8.21
Share price
-3.16%
Change (1 day)
-13.05%
Change (1 year)

P/S ratio for Monte Rosa Therapeutics (GLUE)

P/S ratio as of April 2025 (TTM): 4.11

According to Monte Rosa Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.39. At the end of 2024 the company had a P/S ratio of 5.74.

P/S ratio history for Monte Rosa Therapeutics from 2021 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20245.74
2023N/A
2022N/A
2021N/A